Allspring Global Investments Holdings LLC Buys 25,626 Shares of ICU Medical, Inc. (NASDAQ:ICUI)

Allspring Global Investments Holdings LLC raised its stake in ICU Medical, Inc. (NASDAQ:ICUI) by 32.6% during the 4th quarter, Holdings Channel reports. The fund owned 104,253 shares of the medical instruments supplier’s stock after acquiring an additional 25,626 shares during the period. Allspring Global Investments Holdings LLC’s holdings in ICU Medical were worth $10,398,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors have also recently bought and sold shares of the stock. Covestor Ltd increased its holdings in shares of ICU Medical by 86.4% during the first quarter. Covestor Ltd now owns 123 shares of the medical instruments supplier’s stock worth $27,000 after purchasing an additional 57 shares during the period. Private Trust Co. NA increased its holdings in shares of ICU Medical by 1,428.6% during the third quarter. Private Trust Co. NA now owns 321 shares of the medical instruments supplier’s stock worth $38,000 after purchasing an additional 300 shares during the period. Point72 Hong Kong Ltd bought a new position in shares of ICU Medical during the first quarter worth approximately $94,000. Group One Trading L.P. increased its holdings in shares of ICU Medical by 54.6% during the first quarter. Group One Trading L.P. now owns 566 shares of the medical instruments supplier’s stock worth $126,000 after purchasing an additional 200 shares during the period. Finally, Lazard Asset Management LLC bought a new position in shares of ICU Medical during the third quarter worth approximately $68,000. 96.10% of the stock is owned by institutional investors.

Insider Buying and Selling

In other ICU Medical news, Director George A. Lopez sold 1,890 shares of the firm’s stock in a transaction that occurred on Monday, March 11th. The shares were sold at an average price of $104.22, for a total value of $196,975.80. Following the sale, the director now owns 317,753 shares in the company, valued at $33,116,217.66. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In other ICU Medical news, COO Christian B. Voigtlander sold 13,603 shares of the firm’s stock in a transaction that occurred on Monday, March 4th. The shares were sold at an average price of $107.19, for a total value of $1,458,105.57. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, Director George A. Lopez sold 1,890 shares of the firm’s stock in a transaction that occurred on Monday, March 11th. The shares were sold at an average price of $104.22, for a total transaction of $196,975.80. Following the completion of the sale, the director now owns 317,753 shares in the company, valued at approximately $33,116,217.66. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 24,262 shares of company stock worth $2,545,532. Corporate insiders own 6.70% of the company’s stock.

ICU Medical Stock Performance

NASDAQ ICUI opened at $96.33 on Wednesday. The company has a current ratio of 2.53, a quick ratio of 1.06 and a debt-to-equity ratio of 0.74. The firm has a market capitalization of $2.35 billion, a price-to-earnings ratio of -78.32 and a beta of 0.69. The firm’s 50 day simple moving average is $102.48 and its 200 day simple moving average is $98.81. ICU Medical, Inc. has a 1 year low of $78.28 and a 1 year high of $212.43.

ICU Medical (NASDAQ:ICUI) last posted its quarterly earnings results on Tuesday, February 27th. The medical instruments supplier reported $1.24 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.85 by $0.39. The business had revenue of $587.86 million for the quarter, compared to analyst estimates of $564.77 million. ICU Medical had a negative net margin of 1.31% and a positive return on equity of 6.35%. As a group, research analysts expect that ICU Medical, Inc. will post 3.52 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Separately, KeyCorp increased their price target on shares of ICU Medical from $134.00 to $136.00 and gave the stock an “overweight” rating in a research report on Wednesday, February 28th. One analyst has rated the stock with a hold rating and two have assigned a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $123.00.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.